Kevin Waters
Anatomic Pathology & Clinical Pathology · Baltimore, MDNPI 1881950475
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,471 of the $23,688 with a category attached, or 86.4%. Astellas Pharma US Inc accounts for 80.2% of it on its own, with 4 other manufacturers making up the rest. Among anatomic pathology & clinical pathology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $877.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$19K
- Gilead$2K
- AstraZeneca$2K
- Seagen Inc.$144
- Kerecis Limited$22
What the payments were for
- Consulting fees$20,47186%
- Travel & lodging$2,40210%
- Food & beverage$8153%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $18,993 |
| Gilead | 7 | $2,411 |
| AstraZeneca | 1 | $2,118 |
| Seagen Inc. | 1 | $144 |
| Kerecis Limited | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,688 in reported general payments places this provider in the 90th percentile of 186 anatomic pathology & clinical pathology providers in Maryland.
See all anatomic pathology & clinical pathology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Baltimore
- Aatur SinghiBaltimore$133K
- Brigitte RonnettBaltimore$112K
- Robert KurmanBaltimore$110K
- Robert AndersBaltimore$92K
- Kelly Brenan RothschildBaltimore$67K
- Edward McCarthyBaltimore$63K
- Jonathan EpsteinBaltimore$33K
- Angelo DemarzoBaltimore$26K
- Karen CarrollBaltimore$14K
- Michael BorowitzBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.